• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物溶解度:重要性及增强技术

Drug solubility: importance and enhancement techniques.

作者信息

Savjani Ketan T, Gajjar Anuradha K, Savjani Jignasa K

机构信息

Institute of Pharmacy, Nirma University, Sarkhej Gandhinagar Highway, Gujarat, Ahmedabad 382481, India.

出版信息

ISRN Pharm. 2012;2012:195727. doi: 10.5402/2012/195727. Epub 2012 Jul 5.

DOI:10.5402/2012/195727
PMID:22830056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3399483/
Abstract

Solubility, the phenomenon of dissolution of solute in solvent to give a homogenous system, is one of the important parameters to achieve desired concentration of drug in systemic circulation for desired (anticipated) pharmacological response. Low aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic development. More than 40% NCEs (new chemical entities) developed in pharmaceutical industry are practically insoluble in water. Solubility is a major challenge for formulation scientist. Any drug to be absorbed must be present in the form of solution at the site of absorption. Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction, crystal engineering, salt formation, solid dispersion, use of surfactant, complexation, and so forth. Selection of solubility improving method depends on drug property, site of absorption, and required dosage form characteristics.

摘要

溶解度是溶质在溶剂中溶解形成均匀体系的现象,是在体循环中达到所需药物浓度以产生预期药理反应的重要参数之一。低水溶性是新化学实体制剂开发以及仿制药开发中遇到的主要问题。制药行业开发的超过40%的新化学实体实际上不溶于水。溶解度是制剂科学家面临的一项重大挑战。任何要被吸收的药物都必须以溶液形式存在于吸收部位。人们使用了各种技术来提高难溶性药物的溶解度,包括药物的物理和化学修饰以及其他方法,如减小粒径、晶体工程、成盐、固体分散、使用表面活性剂、络合等。溶解度提高方法的选择取决于药物性质、吸收部位和所需剂型特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8057/3399483/b414b0e2095e/ISRN.PHARMACEUTICS2012-195727.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8057/3399483/93eeeedcb26b/ISRN.PHARMACEUTICS2012-195727.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8057/3399483/b414b0e2095e/ISRN.PHARMACEUTICS2012-195727.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8057/3399483/93eeeedcb26b/ISRN.PHARMACEUTICS2012-195727.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8057/3399483/b414b0e2095e/ISRN.PHARMACEUTICS2012-195727.002.jpg

相似文献

1
Drug solubility: importance and enhancement techniques.药物溶解度:重要性及增强技术
ISRN Pharm. 2012;2012:195727. doi: 10.5402/2012/195727. Epub 2012 Jul 5.
2
APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.用于提高难溶性药物溶解度的各种聚合物及基于聚合物的技术的应用:综述
Acta Pol Pharm. 2017 Mar;74(2):347-356.
3
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.难溶性药物和治疗剂的生物利用度提高技术
Biomedicines. 2022 Aug 23;10(9):2055. doi: 10.3390/biomedicines10092055.
4
Solubility enhancement of simvastatin: a review.辛伐他汀的溶解度增强:综述
Acta Pol Pharm. 2012 Jul-Aug;69(4):581-90.
5
A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.提高难溶性药物溶解度的技术方法:固溶技术。
Curr Drug Deliv. 2020;17(8):638-650. doi: 10.2174/1567201817666200516155733.
6
Nanosizing of drugs: Effect on dissolution rate.药物纳米化:对溶解速率的影响。
Res Pharm Sci. 2015 Mar-Apr;10(2):95-108.
7
Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.基于微波技术的用于提高难溶性药物格列吡嗪溶解度和溶出度的生物纳米复合材料:体外和体内研究。
J Pharm Pharmacol. 2013 Jan;65(1):79-93. doi: 10.1111/j.2042-7158.2012.01584.x. Epub 2012 Nov 1.
8
Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs.提高难溶性药物溶解度的固体分散技术制备方法概述及其在抗癌药物中的应用
Pharmaceutics. 2019 Mar 19;11(3):132. doi: 10.3390/pharmaceutics11030132.
9
Solubility and dissolution enhancement strategies: current understanding and recent trends.溶解度和溶出度提高策略:当前认识与最新趋势
Drug Dev Ind Pharm. 2015 Jun;41(6):875-87. doi: 10.3109/03639045.2014.971027. Epub 2014 Oct 24.
10
Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.超临界流体技术在固体分散体中的应用,以提高难溶性药物的溶解度和生物利用度。
Int J Pharm. 2021 Dec 15;610:121247. doi: 10.1016/j.ijpharm.2021.121247. Epub 2021 Nov 2.

引用本文的文献

1
Two-Step Nucleation and Amorphization of Carbamazepine Using a Micro-Droplet Precipitation System.使用微滴沉淀系统实现卡马西平的两步成核与非晶化
Pharmaceutics. 2025 Aug 9;17(8):1035. doi: 10.3390/pharmaceutics17081035.
2
Generation of Formates Following 20 kHz Sonication of DSPE-mPEG2000 PEGylated Phospholipid Micelles.DSPE-mPEG2000聚乙二醇化磷脂微泡在20 kHz超声处理后甲酸盐的生成
Pharmaceutics. 2025 Aug 1;17(8):1008. doi: 10.3390/pharmaceutics17081008.
3
Drug Nanocarriers for Pharmaceutical Applications.用于药物应用的药物纳米载体

本文引用的文献

1
Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.固体分散体作为一种提高难溶性药物利托那韦生物利用度的方法。
AAPS PharmSciTech. 2010 Jun;11(2):518-27. doi: 10.1208/s12249-010-9404-1. Epub 2010 Mar 18.
2
The role of cocrystals in pharmaceutical science.共晶在药物科学中的作用。
Drug Discov Today. 2008 May;13(9-10):440-6. doi: 10.1016/j.drudis.2008.03.004. Epub 2008 Apr 22.
3
Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note.某些难溶性抗糖尿病药物的胶束增溶作用:技术说明
Pharmaceutics. 2025 Jul 25;17(8):960. doi: 10.3390/pharmaceutics17080960.
4
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3)‑ones as Potential Antileukemic Agents.2-取代喹唑啉-4(3)-酮作为潜在抗白血病药物的合成与评价
ACS Omega. 2025 Aug 1;10(31):34882-34894. doi: 10.1021/acsomega.5c04106. eCollection 2025 Aug 12.
5
Computationally accelerated identification of P-glycoprotein inhibitors.P-糖蛋白抑制剂的计算加速鉴定
PLoS One. 2025 Aug 13;20(8):e0325121. doi: 10.1371/journal.pone.0325121. eCollection 2025.
6
Hybrid Uracil Derivatives with Caffeine and Gramine Obtained via Click Chemistry as Potential Antioxidants and Inhibitors of Plant Pathogens.通过点击化学获得的含咖啡因和禾草碱的杂合尿嘧啶衍生物作为潜在的抗氧化剂和植物病原体抑制剂
Molecules. 2025 Jun 24;30(13):2714. doi: 10.3390/molecules30132714.
7
Synthesis, biological evaluation, pharmacological profiling, and molecular docking studies of 4-Aminocoumarin based phenyliodonium derivatives as potent therapeutic agents.基于4-氨基香豆素的苯基碘鎓衍生物作为有效治疗剂的合成、生物学评价、药理学分析及分子对接研究
Sci Rep. 2025 Jul 1;15(1):21762. doi: 10.1038/s41598-025-95078-8.
8
Hot Melt Extruded Aceclofenac-Soluplus® Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced Dissolution.热熔挤出醋氯芬酸-固体分散体:增强溶出度的混溶性及药物-载体相互作用的机理研究
AAPS PharmSciTech. 2025 Jul 1;26(6):180. doi: 10.1208/s12249-025-03173-w.
9
Unveiling the Structure of Anhydrous Sodium Valproate with 3D Electron Diffraction and a Facile Sample Preparation Workflow.利用三维电子衍射和简便的样品制备流程揭示无水丙戊酸钠的结构
ACS Cent Sci. 2025 May 21;11(6):960-966. doi: 10.1021/acscentsci.5c00412. eCollection 2025 Jun 25.
10
Characterisation and In Vitro Drug Release Profiles of Oleanolic Acid- and Asiatic Acid-Loaded Solid Lipid Nanoparticles (SLNs) for Oral Administration.用于口服给药的齐墩果酸和积雪草苷负载固体脂质纳米粒(SLNs)的表征及体外药物释放曲线
Pharmaceutics. 2025 May 30;17(6):723. doi: 10.3390/pharmaceutics17060723.
AAPS PharmSciTech. 2008;9(2):431-6. doi: 10.1208/s12249-008-9057-5. Epub 2008 Mar 5.
4
Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation.用于多晶型控制和复合物形成的活性药物成分的超临界二氧化碳处理
Adv Drug Deliv Rev. 2008 Feb 14;60(3):328-38. doi: 10.1016/j.addr.2007.03.023. Epub 2007 Oct 5.
5
Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.超临界流体技术:一种操控药物固态的创新方法。
Adv Drug Deliv Rev. 2008 Feb 14;60(3):399-410. doi: 10.1016/j.addr.2007.08.030. Epub 2007 Oct 5.
6
Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process.通过超快速冷冻工艺生产的快速溶解型瑞格列奈粉末。
AAPS PharmSciTech. 2007 Jul 20;8(3):E58. doi: 10.1208/pt0803058.
7
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.通过晶体工程优化活性药物成分以提高溶解度和溶出速率。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30. doi: 10.1016/j.addr.2007.05.011. Epub 2007 May 29.
8
Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.通过微粉化、共研磨和喷雾干燥提高非诺贝特的溶出度:与市售制剂的比较。
Eur J Pharm Biopharm. 2008 Feb;68(2):283-8. doi: 10.1016/j.ejpb.2007.05.010. Epub 2007 May 21.
9
Performance comparison of a co-crystal of carbamazepine with marketed product.卡马西平共晶体与市售产品的性能比较。
Eur J Pharm Biopharm. 2007 Aug;67(1):112-9. doi: 10.1016/j.ejpb.2006.12.016. Epub 2006 Dec 28.
10
Design and evaluation of celecoxib porous particles using melt sonocrystallization.使用熔体声结晶法设计和评估塞来昔布多孔颗粒
Pharm Res. 2006 Jun;23(6):1395-400. doi: 10.1007/s11095-006-0020-4. Epub 2006 Jun 7.